GLP-1 RAs Associated With Small ION Risk Increase - Top-Institutions - MDSpire

GLP-1 RAs Associated With Small ION Risk Increase

In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.

  • By

  • Andrea Surnit

  • July 13, 2026

  • 5 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Rutgers University
    Rutgers University

    New Brunswick, NJ

    Key Differentiators

    • Endocrinology

  • #2

    McGill University
    McGill University

    Montreal, QC

    Key Differentiators

    • Endocrinology

  • #3

    University of Toronto
    University of Toronto

    Toronto, ON

    Key Differentiators

    • Endocrinology

  • #4

    Institute for Clinical Evaluative Sciences
    Institute for Clinical Evaluative Sciences

    Toronto, ON

    Key Differentiators

    • Endocrinology

Original Source(s)

GLP-1 RAs Associated With Small ION Risk Increase

  • by Andrea Surnit

  • July 13, 2026

Related Content

Is Accelerated Aging Tied to Early-Onset Carcinogenesis?

Researchers found larger biological age gaps in more recent birth cohorts and observed associations with higher risk of several cancers diagnosed before age 55.

FDA Expands OTC CGM Access to Children

The device was previously cleared for adults aged 18 years and older in March 2024.

Does Weight Loss Intervention Improve Persistent AF?

Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.